Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015

SAN DIEGO, Aug. 3, 2015 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today announced that it will host its First Quarter Fiscal 2016 investor conference call and webcast on Thursday, August 13, 2015 at 4:30 p.m. Eastern Time.

Aethlon Hemopurifier.

The call and webcast will follow the release of fiscal 2016 first quarter results.  A recorded version of the call will be available approximately two hours after the call at the Investor Relations portion of the company's website,

Conference Call Details

What: Aethlon's First Quarter Fiscal 2016 Investor Conference Call and Webcast

Date: Thursday, August 13, 2015

Time: 4:30 p.m. Eastern Time

Live call: 412-902-6510

International: 877-270-2148

Audio Replay: 412-317-0088

Passcode: 10070531

About Aethlon Medical, Inc.

Aethlon Medical creates affinity biofiltration devices to treat life-threatening diseases. Our lead therapeutic candidate is the Aethlon Hemopurifier®, a first-in-class device that targets the rapid elimination of infectious viruses and cancer-promoting exosomes from the circulatory system of treated individuals. U.S. clinical progression of Hemopurifier therapy is being advanced under an FDA approved clinical study. We also provide government contracting services to the Defense Advanced Research Projects Agency related to the development of a biofiltration device to treat sepsis. Additional information can be found online at or you can connect with us on on Twitter, LinkedIn, Facebook and Google+.


James A. Joyce
Chairman and CEO
(Office) 858.459.7800 x301
(Cell) 619-368-2000

Jim Frakes
Chief Financial Officer
858.459.7800 x300  

Mike Smargiassi/Brad Edwards
Brainerd Communicators, Inc

Photo -


To view the original version on PR Newswire, visit:

SOURCE Aethlon Medical, Inc.